Search
for
Sort by
Research 481–510 of 578
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- Clinical and Laboratory Follow-up After Hospitalization for COVID-19 at an Italian Tertiary Care Center
- Unsuccessful Treatment of Alopecia Areata with Simvastatin/Ezetimibe: Experience in 12 Patients
- Transverse Needling After Autologous Mini-Punch Grafts Improves Repigmentation in Stable Non-Segmental Vitiligo
- Single‐cell transcriptomics reveals a senescence‐associated IL ‐6/ CCR6 axis driving radiodermatitis
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Using qualitative methods to establish the clinically meaningful threshold for treatment success in alopecia areata
- Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan
- Baricitinib for the Treatment of Alopecia Areata
- Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
- Epithelial-Mesenchymal Interaction in Hair Regeneration and Skin Wound Healing
- Single-cell analysis of temporal immune cell dynamics in alopecia areata reveals a causal role for clonally expanded CD8+ T cells in disease
- A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database
- Molecular Mechanisms of Hair Follicle Development
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- COVID-19: The question of genetic diversity and therapeutic intervention approaches
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Safety and Efficacy of Ritlecitinib for the Treatment of Patients with Alopecia Areata: A Systematic Review and Meta-Analysis of Controlled Trials
- Predominant expression of interleukin (IL)‐17 in chronic alopecia areata compared to IFN‐γ in pathogenic Th17 cells, tissue‐resident memory T cells and natural killer cells
- Alopecia areata: a comprehensive review of clinical, immunologic, and genetic perspectives
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
- Identifying barriers and disparities in the healthcare of patients with alopecia areata: a mixed-methods analysis using claims data and qualitative interview data
- Regulation and dysregulation of hair regeneration: aiming for clinical application
- Bitemporal Scalp Hair Loss: Differential Diagnosis of Nonscarring and Scarring Conditions.
- Pili trianguli et canaliculi as a phenotypic subtype in patients with central centrifugal cicatricial alopecia: A scanning electron microscopy study
- Alopecia Areata: Clinical Treatment
- Systemic Tofacitinib in Alopecia Areata: A Single Center Retrospective Descriptive Cohort Study
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Inheritance-Specific Dysregulation of Th1- and Th17-Associated Cytokines in Alopecia Areata